Identifying markers for pancreatic cancer by gene expression analysis - PubMed (original) (raw)
L J Sokoll, D J Bruzek, L Zhang, V E Velculescu, S B Goldin, R H Hruban, S E Kern, S R Hamilton, D W Chan, B Vogelstein, K W Kinzler
Affiliations
- PMID: 9488584
Identifying markers for pancreatic cancer by gene expression analysis
W Zhou et al. Cancer Epidemiol Biomarkers Prev. 1998 Feb.
Abstract
To begin to identify new tumor markers, we recently performed a systematic study of gene expression in cancers of the colon and pancreas. Of the 45,000 genes identified, 183 were found to be expressed at significantly elevated levels in pancreatic cancer. One of the genes was tissue inhibitor of metalloproteinase type I (TIMP-1), which encodes a secreted protein. Analysis of TIMP-1 serum levels revealed significant increases in pancreatic cancer patients, but TIMP-1 by itself was inadequate as a serum marker for cancer. However, a combination of individually suboptimal markers (TIMP-1, CA19-9, and carcinoembryonic antigen) detected 60% of 85 patients with pancreatic cancers in a highly specific manner. These results suggest that a systematic analysis of gene expression can reveal novel serum markers and that individually suboptimal markers can be combined to yield higher sensitivity and specificity.
Similar articles
- CEACAM1, a novel serum biomarker for pancreatic cancer.
Simeone DM, Ji B, Banerjee M, Arumugam T, Li D, Anderson MA, Bamberger AM, Greenson J, Brand RE, Ramachandran V, Logsdon CD. Simeone DM, et al. Pancreas. 2007 May;34(4):436-43. doi: 10.1097/MPA.0b013e3180333ae3. Pancreas. 2007. PMID: 17446843 - The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P. Ni XG, et al. Eur J Surg Oncol. 2005 Mar;31(2):164-9. doi: 10.1016/j.ejso.2004.09.007. Eur J Surg Oncol. 2005. PMID: 15698733 - Clinical significance of the measurements of serum matrix metalloproteinase-9 and its inhibitor (tissue inhibitor of metalloproteinase-1) in patients with pancreatic cancer: metalloproteinase-9 as an independent prognostic factor.
Mroczko B, Lukaszewicz-Zajac M, Wereszczynska-Siemiatkowska U, Groblewska M, Gryko M, Kedra B, Jurkowska G, Szmitkowski M. Mroczko B, et al. Pancreas. 2009 Aug;38(6):613-8. doi: 10.1097/MPA.0b013e3181a488a0. Pancreas. 2009. PMID: 19629003 - [Tumor markers for pancreatic and biliary tract cancer].
Takezako Y, Okusaka T, Ueno H, Ikeda M, Morizane C, Najima M. Takezako Y, et al. Gan To Kagaku Ryoho. 2004 Sep;31(9):1443-6. Gan To Kagaku Ryoho. 2004. PMID: 15446574 Review. Japanese. - CA19-9: the Italian experience.
Gullo L. Gullo L. Pancreas. 1994 Nov;9(6):717-9. Pancreas. 1994. PMID: 7846014 Review.
Cited by
- The TIMP protein family: diverse roles in pathophysiology.
Coates-Park S, Rich JA, Stetler-Stevenson WG, Peeney D. Coates-Park S, et al. Am J Physiol Cell Physiol. 2024 Mar 1;326(3):C917-C934. doi: 10.1152/ajpcell.00699.2023. Epub 2024 Jan 29. Am J Physiol Cell Physiol. 2024. PMID: 38284123 Review. - Screening for pancreatic cancer has the potential to save lives, but is it practical?
Mazer BL, Lee JW, Roberts NJ, Chu LC, Lennon AM, Klein AP, Eshleman JR, Fishman EK, Canto MI, Goggins MG, Hruban RH. Mazer BL, et al. Expert Rev Gastroenterol Hepatol. 2023 Jan-Jun;17(6):555-574. doi: 10.1080/17474124.2023.2217354. Epub 2023 Jul 3. Expert Rev Gastroenterol Hepatol. 2023. PMID: 37212770 Free PMC article. Review. - Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma.
Firpo MA, Boucher KM, Bleicher J, Khanderao GD, Rosati A, Poruk KE, Kamal S, Marzullo L, De Marco M, Falco A, Genovese A, Adler JM, De Laurenzi V, Adler DG, Affolter KE, Garrido-Laguna I, Scaife CL, Turco MC, Mulvihill SJ. Firpo MA, et al. JCO Clin Cancer Inform. 2023 Mar;7:e2200160. doi: 10.1200/CCI.22.00160. JCO Clin Cancer Inform. 2023. PMID: 36913644 Free PMC article. - Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data.
Boyd LNC, Ali M, Leeflang MMG, Treglia G, de Vries R, Le Large TYS, Besselink MG, Giovannetti E, van Laarhoven HWM, Kazemier G. Boyd LNC, et al. EClinicalMedicine. 2022 Nov 24;55:101747. doi: 10.1016/j.eclinm.2022.101747. eCollection 2023 Jan. EClinicalMedicine. 2022. PMID: 36457649 Free PMC article. - Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer.
Jaworski JJ, Morgan RD, Sivakumar S. Jaworski JJ, et al. Cancers (Basel). 2020 Dec 9;12(12):3704. doi: 10.3390/cancers12123704. Cancers (Basel). 2020. PMID: 33317202 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous